Nuwiq, Human cell line recombinant human factor VIII (Human-cl rhFVIII) 4000 IU powder and solvent for solution for injection. Vial of powder and prefilled WFI syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

nuwiq, human cell line recombinant human factor viii (human-cl rhfviii) 4000 iu powder and solvent for solution for injection. vial of powder and prefilled wfi syringe

octapharma australia pty ltd - simoctocog alfa, quantity: 4000 iu - injection, powder for - excipient ingredients: poloxamer; arginine hydrochloride; sucrose; sodium chloride; sodium citrate dihydrate; calcium chloride dihydrate - treatment and prophylaxis of bleeding (also during and after surgery) in previously treated paediatric (>= 2 years) and adult patients with haemophilia a (congenital factor viii deficiency). nuwiq does not contain von willebrand factor and is thus not indicated to treat von willebrand?s disease.

Nuwiq, Human cell line recombinant human factor VIII (Human-cl rhFVIII) 3000 IU powder and solvent for solution for injection. Vial of powder and prefilled WFI syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

nuwiq, human cell line recombinant human factor viii (human-cl rhfviii) 3000 iu powder and solvent for solution for injection. vial of powder and prefilled wfi syringe

octapharma australia pty ltd - simoctocog alfa, quantity: 3000 iu - injection, powder for - excipient ingredients: poloxamer; arginine hydrochloride; sucrose; sodium chloride; sodium citrate dihydrate; calcium chloride dihydrate - treatment and prophylaxis of bleeding (also during and after surgery) in previously treated paediatric (>= 2 years) and adult patients with haemophilia a (congenital factor viii deficiency). nuwiq does not contain von willebrand factor and is thus not indicated to treat von willebrand?s disease.

Nuwiq, Human cell line recombinant human factor VIII (Human-cl rhFVIII) 2500 IU powder and solvent for solution for injection. Vial of powder and prefilled WFI syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

nuwiq, human cell line recombinant human factor viii (human-cl rhfviii) 2500 iu powder and solvent for solution for injection. vial of powder and prefilled wfi syringe

octapharma australia pty ltd - simoctocog alfa, quantity: 2500 iu - injection, powder for - excipient ingredients: poloxamer; arginine hydrochloride; sucrose; sodium chloride; sodium citrate dihydrate; calcium chloride dihydrate - treatment and prophylaxis of bleeding (also during and after surgery) in previously treated paediatric (>= 2 years) and adult patients with haemophilia a (congenital factor viii deficiency). nuwiq does not contain von willebrand factor and is thus not indicated to treat von willebrand?s disease.

NUWIQ 250 IU INJECTION Sør-Afrika - engelsk - South African Health Products Regulatory Authority (SAHPRA)

nuwiq 250 iu injection

octapharma south africa (pty) ltd - injection - see ingredients - each vial contains simoctocog alfa, coagulation factor viii 250,0 iu

NUWIQ 500 IU INJECTION Sør-Afrika - engelsk - South African Health Products Regulatory Authority (SAHPRA)

nuwiq 500 iu injection

octapharma south africa (pty) ltd - injection - see ingredients - each vial contains simoctocog alfa, coagulation factor viii 500,0 iu

NUWIQ 1 000 IU INJECTION Sør-Afrika - engelsk - South African Health Products Regulatory Authority (SAHPRA)

nuwiq 1 000 iu injection

octapharma south africa (pty) ltd - injection - see ingredients - each vial contains simoctocog alfa, coagulation factor viii 1 000,0 iu

NUWIQ 2 000 IU INJECTION Sør-Afrika - engelsk - South African Health Products Regulatory Authority (SAHPRA)

nuwiq 2 000 iu injection

octapharma south africa (pty) ltd - injection - see ingredients - each vial contains simoctocog alfa, coagulation factor viii 2 000,0 iu